Characteristics | Facility category | ||
---|---|---|---|
Exposed n (%) | Unexposed n (%) | P value | |
ART Enrolment year | |||
2005–2007 | 408 (22.1) | 1569 (25.6) | 0.08 |
2008–2010 | 639 (34.6) | 2179 (35.5) | |
2011–2013 | 433 (23.4) | 1244 (20.3) | |
2014–2017 | 369 (20.0) | 1138 (18.6) | |
Gender | |||
Male | 747 (40.3) | 2602 (42.3) | 0.13 |
Female | 1107 (59.7) | 3553 (57.7) | |
total | 1854 (23.1) | 6155 (76.9) | |
WHO stage at entry | |||
Stage I | 408 (24.3) | 1272 (20.9) | 0.01 |
Stage II | 348 (19.1) | 1592 (26.1) | |
Stage III | 866 (47.5) | 2600 (42.6) | |
Stage IV | 203 (11.1) | 634 (10.4) | |
Functional status at entry | |||
Bedridden | 130 (7.3) | 353 (5.9) | 0.07 |
Ambulatory | 580 (32.5) | 1515 (25.3) | |
Working | 1072 (60.2) | 4116 (68.8) | |
TB Coinfection | |||
No (−ve) | 1467 (79.1) | 5138 (83.5) | 0.01 |
Yes (+ve) | 387 (20.9) | 1017 (16.5) | |
INH prophylaxis | |||
Yes | 865 (46.7) | 3222 (52.3) | 0.01 |
No | 989 (53.3) | 2933 (47.7) | |
Ever Regimen Substitution | |||
No | 1326 (71.5) | 4503 (73.2) | 0.23 |
Yes | 528 (28.5) | 1652 (26.8) | |
Ever Regimen Switch | |||
No | 1819 (98.1) | 6101 (99.1) | 0.01 |
Yes | 35 (1.9) | 54 (0.9) | |
Viral load Test (n = 1512) | 270 | 1242 | |
Detectable | 41 (15.2) | 305 (24.6) | 0.01 |
Not Detectable | 229 (84.8) | 937 (75.4) |